The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 336:1328-1329 May 1, 1997 Number 18
NextNext

Ataxia and Slurred Speech after Artesunate Treatment for Falciparum Malaria

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
-PubMed Citation
To the Editor: Artemisinin compounds are used to treat Plasmodium falciparum infections in many countries worldwide.1,2 We describe a patient with acute cerebellar dysfunction that was temporally associated with the ingestion of artesunate.

In July 1996, a 36-year-old American geologist in Ghana had fever and chills without associated neurologic symptoms. His blood smear revealed P. falciparum. He proceeded to a local market and purchased a pack of artesunate tablets manufactured in China. He took two tablets on day 1, followed by one tablet daily for the next four days. He became afebrile on day 2. A blood smear on day . . . [Full Text of this Article]

References


Related Letters:

Artesunate and Cerebellar Dysfunction in Falciparum Malaria
Davis T. M.E., Edwards G. O., McCarthy J. S., Gachot B., Eliaszewicz M., Dupont B., Miller L. G., Panosian C. B.
Extract | Full Text  
N Engl J Med 1997; 337:792-793, Sep 11, 1997. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.